1. Promoting Diversity and Science for Health Equity -- Introduction of NIDA Minority Diversity Programs Yu (Woody) Lin, M.D., Ph.D Program Director Division of Clinical Neuroscience and Behavior Research National Institute on Drug Abuse/NIH

2. NIH Mission NIH is the steward of medical and behavioral research for the Nation Our mission: to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability … Support research by non-Federal scientists across U.S. and abroad Help train research investigators Foster communication of medical and health sciences information

3. Training 2% $722 Million Research Project Grants 53% $16.42 Billion Research Project Grants 53% $16.42 Billion Total NIH Budget Authority – FY 2011 Total NIH Budget Authority – FY 2011 $32.23 Billion

4. NIDA’s Mission - Support and conduct cross-disciplinary research to better understand, treat and prevent drug abuse and addiction - Disseminate research results to improve prevention, treatment, and policy Bring the power of science to bear research on drug abuse and addiction

5. From Molecules…

6. NIDA BUDGET (Thousands) IncreaseOver Prior Year AIDS TOTAL NonAIDS 2011 $731,428 $317,348 $1,048,776 -1.0% 2012 $732,822 $319,292 $1,052,114 0.3% 2013 PB $732,838 $321,163 $1,054,001 0.2%

7. National Institute on Drug Abuse Portfolio FY 2010 Actual Epidemiology, Services & Prevention Research -- 23% Basic & Clinical Neuroscience & Behavioral Research -- 46% Pharmacotherapies & Medical Consequences -- 12% Intramural Research -- 8% Clinical Trials Network -- 4% RM&S -- 6%

8. National Institute on Drug Abuse Office of Extramural Affairs Teresa Levitin, PhD Gender Research Cora Lee Wetherington, PhD HIV/AIDS Research Jacques Normand, PhD International Program Steve Gust, PhD Office of Planning & Resource Management Helio Chaves Office of Science Policy & Communications Susan Weiss, PhD Center for the Clinical Trials Network Betty Tai, PhD Division of Basic Neuroscience & Behavioral Research Joni Rutter, PhD Division of Pharmacotherapies & Medical Consequences of Drug Abuse David McCann, PhD Division of Epidemiology, Services & Prevention Research Wilson Compton, MD, MPE Division of Clinical Neuroscience & Behavioral Research Joseph Frascella, PhD Intramural Research Program Anto Bonci, MD Special Populations Office David Shurtleff, PhD Office of the Director Nora D. Volkow, MD Director David Shurtleff, PhD Acting Deputy Director Glenda Conroy Executive Officer

9. Increase diverse workforce & activity Promote science for health equity Special Populations Office (SPO)

10. SPO DIRECTOR NIDA Diversity Research Program SPO STAFF NHSN Workgroup AA RS Workgroup AAPI RS Workgroup NA/AN RS Workgroup Special Populations Office (SPO) The NIDA SPO coordinates the Institute’s diversity-directed research, concentrating on areas where there are significant gaps in knowledge and/or clear Disparities in prevention and treatment.

11. Researchers & Scholars Workgroups Each Work Group is currently comprised of established researchers and scholars with expertise in drug abuse and addiction research and health concerns of the particular population it represents. 1.Provide guidance and recommendations to NIDA: Drug abuse and addiction research development Training needs within 4 major diverse populations 2.Identify concerns, and stimulate research on drug abuse/addiction associated with particular population it represents. American Indian/ Alaska Native Work Group American Indian/ Alaska Native Work Group African American Work Group African American Work Group

12. SPO Research & Training Programs Promoting Diversity and Science for Health Equity Diversity -promoting Institutions Drug Abuse Research Program (DIDARP) Diversity Supplements Research Development Seminar Series Summer Research with NIDA

13. NIDA Diversity-Promoting Institutions Drug Abuse Research Program (DIDARP) The overall goal of the DIDARP is the capacity development of the applicant institution to support drug abuse research through the following objectives: http://grants.nih.gov/grants/guide/pa-files/PAR-11-060.html (1) Provide faculty with drug abuse research knowledge and skill development through the conduct of research projects and other professional development activities; (2)Encourage students from disadvantaged backgrounds to pursue drug abuse research careers by providing them with educational enrichment and research experiences; (3) Strengthen the underlying institutional infrastructure needed to support drug abuse research. (4) Budgets up to $350,000 (direct costs/year (5 years); NIDA review, division fund

14. Since 2005, NIDA has supported 15 DIDARPs. There are 11 active DIDARP projects; including these 7 institutions that have not been previously supported: University of Houston Howard University Meharry Medical College Morehouse School of Medicine University of Puerto Rico School of Public Health California State University – San Bernandino University of Hawaii NIDA Program Contact: Pamela Goodlow NIDA Diversity-Promoting Institutions Drug Abuse Research Program (DIDARP)

15. 15 Supplements certain active (> 1 year) research grants Provides mentoring/training for an identified individual from an underrepresented or disadvantaged population : * Racial/Ethnic Minority* Investigator who becomes disabled * Individual with disability* Disadvantaged Background Supports persons at five levels: * High school * Undergraduates * Graduate students* Post doctoral * Investigators NIDA internal review; a NIH-wide program Type/Amount of support varies with levels NIDA Program Contact: Pamela Goodlow Diversity Supplements Program

16. NIDA Diversity Supplement Awards FYNew AwardsContinuing Awards Total Awards FY 199421 42 FY 1995351853 FY 1996412667 FY 1997342862 FY 1998353267 FY 1999412061 FY 2000304171 FY 2001382361 FY 2002312354 FY 2003322658 FY 2004402464 FY 2005382866 FY 200638 76 FY 2007 353671 FY 2008292655 FY 2009321951 Total550979 16

17. Research Development Seminar Series For scholars from diverse populations who are trained & dedicated for independent research on drug abuse yet need technical assistance on grant application process Small group discussion, and one-on-one mentoring provided by NIDA staff and extramural experts in the field of drug abuse and addiction research NIDA Program Contact: Flair Lindsey Provides science and proposal development lectures in 2 training sessions about 6 months apart: First focuses on research design, methods, scientific writing, the peer review process and grant application preparation Second centers on mock review led by NIDA SRA

18. Must prepare a 1-page concept paper Actively participate in proposal development activities Expectation is that your application will be submitted within 6 – 12 months after your last session Research Development Seminar Series Program established in 1986. From 2009 – 2011 NIDA supported 57 early career researchers to attend the Seminar Series

19. Examples of NIDA-Supported Research In Diverse Communities Patterns of Substance Abuse Biological & Behavioral Risk & Protective Factors Relationship of Stress to Drug Use & Other Disorders Culturally Appropriate Prevention Interventions Preventive Interventions with Urban Youth Culturally Appropriate Substance Abuse Treatment Strategies Tobacco Cessation Treatment Services Research

20. NIDA Summer Research Internship Program Supports under-represented high school and undergraduate students in the social sciences and life sciences 8-10 week research placement with NIDA grantees

21. GenderEthnicity FYFMAAHispanicAI/ANAAPITOTAL FY 1997166 51--22 FY 19981571731122 FY 1999318 43139 FY 20002571963432 FY 200125152533940 FY 20025422461281076 FY 20034824431151372 FY 200452185662670 FY 20055826502131084 FY 2006631449172977 FY 200737152914--952 FY 20083618281331054 FY 20094517335--2462 FY 20105023341631473 FY 20115515281611170 TOTAL61023550415238131845 Summer Research with NIDA Program Participation - All Years

22. NIDA Minority Diversity Programs Preparing researchers to better address minority health disparities Stimulating/Encouraging research that will lead to more effective drug abuse and drug abuse related prevention and treatment approaches for racial/ethnic minority populations Increasing the number of racial/ethnic minority researchers engaged in drug abuse and related research 22

23. NIDA Has Made a Commitment in You Believe in your research skills and abilities Your research has the potential to make an impact in the substance abuse and health disparities field

24. Questions?

25. Funding Opportunity Announcements: NIMHD Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01) RFA-MD-12-004RFA-MD-12-004 NIMHD Social, Behavioral, Health Services, and Policy Research on Minority Health and Health Disparities (R01) RFA-MD-12-003 RFA-MD-12-003 Conferences and Scientific Meetings PA-10-071PA-10-071 National Institute on Minority Health and Health Disparities In 2010, NIH announced the transition of the National Center on Minority Health and Health Disparities (NCMHD) into the National Institute on Minority Health and Health Disparities (NIMHD). This transition gives the institute a more defined role in the NIH's research agenda against health disparities, which it defines as differences in the incidence, prevalence, mortality, and burden of diseases and other adverse health conditions that exist among specific population groups.